|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows provided by (used in) operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| (Increase) decrease in the fair value of derivative instruments | |||||
| Depreciation and amortization | |||||
| Provision for losses on accounts receivable | |||||
| Change in deferred taxes | |||||
| Other income, net | |||||
| Changes in operating assets and liabilities net of amounts related to acquisitions: | |||||
| (Increase) decrease in receivables | |||||
| (Increase) decrease in inventories | |||||
| (Increase) decrease in other assets | |||||
| Increase (decrease) in accounts payable | |||||
| (Decrease) increase in customer credit balances | |||||
| Increase (decrease) in other current and long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows provided by (used in) investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sales of fixed assets | |||||
| Proceeds from sale of certain assets | |||||
| Purchase of investments | |||||
| Acquisitions | |||||
| Net cash used in investing activities | |||||
| Cash flows provided by (used in) financing activities: | |||||
| Revolving credit facility borrowings | |||||
| Revolving credit facility repayments | |||||
| Proceeds from term loan | |||||
| Loan repayments | |||||
| Distributions | |||||
| Unit repurchases | |||||
| Customer retainage payments | |||||
| Payments of debt issuance costs | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
Loading...
